Bristol-Myers Squibb Company
BMY
$45.94
$0.150.33%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 81.75% | -22.02% | 120.62% | -95.91% | -37.19% |
| Total Depreciation and Amortization | -60.29% | -61.69% | -59.45% | -24.50% | 6.96% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -82.76% | 269.98% | -97.05% | 252.58% | -51.67% |
| Change in Net Operating Assets | 78.97% | 100.63% | -1,044.95% | 49.24% | 486.60% |
| Cash from Operations | 12.88% | 68.40% | -31.05% | 4.40% | 17.68% |
| Capital Expenditure | 1.23% | -37.79% | 8.45% | -14.55% | 5.26% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -438.51% | 79.24% | 99.61% | 91.91% | -6.75% |
| Divestitures | 9.41% | 0.00% | 0.83% | 38.17% | 3.24% |
| Other Investing Activities | 7.58% | -310.87% | -184.52% | 84.62% | 1,700.00% |
| Cash from Investing | -677.17% | 64.14% | 97.46% | 85.44% | 46.59% |
| Total Debt Issued | -94.74% | -82.21% | -97.69% | -109.59% | 1,050.00% |
| Total Debt Repaid | 91.66% | 79.43% | -- | 100.00% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.87% | -3.70% | -3.80% | -5.00% | -2.10% |
| Other Financing Activities | -118.75% | 283.33% | -6.19% | -- | -58.97% |
| Cash from Financing | 61.32% | 54.36% | -106.78% | -269.80% | 25.35% |
| Foreign Exchange rate Adjustments | -105.19% | 681.82% | 246.67% | -288.46% | 302.63% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 95.05% | 157.14% | 124.16% | -37.89% | 286.35% |